Literature DB >> 18166789

Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation.

Suryasarathi Dasgupta1, Ana Maria Navarrete, Sebastien André, Bharath Wootla, Sandrine Delignat, Yohann Repessé, Jagadeesh Bayry, Antonino Nicoletti, Evgueni L Saenko, Roseline d'Oiron, Marc Jacquemin, Jean-Marie Saint-Remy, Srini V Kaveri, Sebastien Lacroix-Desmazes.   

Abstract

BACKGROUND: The development of factor VIII (FVIII) inhibitors remains the major hurdle in the clinical management of patients with hemophilia A. FVIII uptake by professional antigen-presenting cells (APC) is the first step involved in initiation of immune responses to FVIII. Studies on FVIII catabolism have highlighted the role played by CD91/LRP as a potential target for increasing FVIII half-life in patients and prolonging treatment efficiency. We investigated the involvement of CD91 in FVIII endocytosis by human dendritic cells (DC), a model of professional APC. DESIGN AND METHODS: Immature DC were generated from circulating monocytes from healthy donors. Surface expression of CD91 was assessed by flow cytometry. Uptake of fluorescein isothiocyanate-conjugated ligands by immature DC was studied in the presence of various blocking agents.
RESULTS: CD91 was expressed on approximately 20% of DC and mediated the internalization of its model ligand, alpha2-macroglobulin. DC internalized FVIII and activated a human FVIII-specific T-cell clone in a dose-dependent manner. FVIII uptake by DC and subsequent T-cell activation were not inhibited by receptor-associated protein.
CONCLUSIONS: Our results indicate that CD91 and other members of the LDL receptor family are not strongly implicated in FVIII internalization by monocyte-derived DC, and suggest the involvement of alternative divalent ion-dependent endocytic receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18166789     DOI: 10.3324/haematol.11535

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

1.  Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII.

Authors:  Puneet Gaitonde; Aaron Peng; Robert M Straubinger; Richard B Bankert; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2011-09-23       Impact factor: 3.534

2.  The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.

Authors:  Bagirath Gangadharan; Mathieu Ing; Sandrine Delignat; Ivan Peyron; Maud Teyssandier; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

3.  Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.

Authors:  Y Dargaud; A Pavlova; S Lacroix-Desmazes; K Fischer; M Soucie; S Claeyssens; D W Scott; R d'Oiron; G Lavigne-Lissalde; G Kenet; C Escuriola Ettingshausen; A Borel-Derlon; T Lambert; G Pasta; C Négrier
Journal:  Haemophilia       Date:  2016-01       Impact factor: 4.287

4.  Intravenous administration of Factor VIII-O-Phospho-L-Serine (OPLS) complex reduces immunogenicity and preserves pharmacokinetics of the therapeutic protein.

Authors:  Puneet Gaitonde; Vivek S Purohit; Sathy V Balu-Iyer
Journal:  Eur J Pharm Sci       Date:  2014-10-20       Impact factor: 4.384

5.  Bright expression of CD91 identifies highly activated human dendritic cells that can be expanded by defensins.

Authors:  Monica Cappelletti; Pietro Presicce; Francesca Calcaterra; Domenico Mavilio; Silvia Della Bella
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

6.  Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.

Authors:  Aleksandra Wroblewska; Simon D van Haren; Eszter Herczenik; Paul Kaijen; Aleksandra Ruminska; Sheng-Yu Jin; X Long Zheng; Maartje van den Biggelaar; Anja ten Brinke; Alexander B Meijer; Jan Voorberg
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

7.  Regulatory B Cells Are Functionally Impaired in Patients Having Hemophilia A With Inhibitors.

Authors:  Mohamed-Rachid Boulassel; Maryam Al-Ghonimi; Badriya Al-Balushi; Amal Al-Naamani; Zahra Al-Qarni; Yasser Wali; Mohamed Elshinawy; Maryam Al-Shezawi; Hamad Khan; Hanan Nazir; Doaa Khater; Anil Pathare; Salam Al-Kindi
Journal:  Clin Appl Thromb Hemost       Date:  2017-04-10       Impact factor: 2.389

Review 8.  A cellular viewpoint of anti-FVIII immune response in hemophilia A.

Authors:  Sebastien André; Yann Meslier; Jordan D Dimitrov; Yohann Repessé; Srinivas V Kaveri; Sebastien Lacroix-Desmazes; Suryasarathi Dasgupta
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

9.  Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice.

Authors:  Qizhen Shi; Christopher V Carman; Yingyu Chen; Peter T Sage; Feng Xue; Xin M Liang; Gary E Gilbert
Journal:  Blood Adv       Date:  2020-05-26

Review 10.  To clear or to fear: An innate perspective on factor VIII immunity.

Authors:  Jesse Derek Lai; Maria Teofana Georgescu; Christine Hough; David Lillicrap
Journal:  Cell Immunol       Date:  2015-10-28       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.